Skip to main content
. 2010 Jul;177(1):29–38. doi: 10.2353/ajpath.2010.090812

Figure 5.

Figure 5

Clinical correlation of gliomas with miR-182 confirmed by real-time RT-PCR analysis. A: Statistical analyses of the average relative miR-182 expression between normal brain tissues (three cases) and glioma specimens of different World Health Organization (WHO) grades (WHO grade I tumors, 13; grade II, 30; grade III, 54; and grade IV, 22; *P < 0.05). B: The cumulative 5-year survival rate was 54.12% (95% confidence interval, 0.432 to 0.650) in the low-miR-182 expression group (n = 46), whereas it was only 9.08% (95% confidence interval, 0.032 to 0.144) in the high-miR-182 expression group (n = 73).